通过最低抑菌浓度（MIC）及纸片洗脱法对耐多药结核分枝杆菌和鸟分枝杆菌复合群进行环丙沙星药敏试验。
Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex.
作者信息
LaBombardi V J, Cataldo-Caputzal L
机构信息
Clinical Microbiology Laboratory, St. Vincent's Hospital and Medical Center, New York, New York 10011.
出版信息
Antimicrob Agents Chemother. 1993 Jul;37(7):1556-7. doi: 10.1128/AAC.37.7.1556.
Abstract
The ability to provide susceptibility data for certain species of mycobacteria can be clinically useful. In this study, the disk elution method for susceptibility testing was adapted for testing ciprofloxacin against mycobacterial isolates. Of the 75 Mycobacterium tuberculosis isolates tested, including 23 multiply drug-resistant isolates, 96% were susceptible to ciprofloxacin at a breakpoint concentration of 2 micrograms/ml.
摘要
提供某些分枝杆菌物种药敏数据的能力在临床上可能有用。在本研究中，药敏试验的纸片洗脱法被用于测试环丙沙星对分枝杆菌分离株的敏感性。在测试的75株结核分枝杆菌分离株中，包括23株多重耐药分离株，在2微克/毫升的断点浓度下，96%对环丙沙星敏感。
相似文献
1
Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex.通过最低抑菌浓度（MIC）及纸片洗脱法对耐多药结核分枝杆菌和鸟分枝杆菌复合群进行环丙沙星药敏试验。
Antimicrob Agents Chemother. 1993 Jul;37(7):1556-7. doi: 10.1128/AAC.37.7.1556.
2
Etest for susceptibility testing of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare.用于结核分枝杆菌和鸟分枝杆菌-胞内分枝杆菌药敏试验的Etest法。
Diagn Microbiol Infect Dis. 1994 Jul;19(3):179-81. doi: 10.1016/0732-8893(94)90064-7.
3
Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.环丙沙星对分枝杆菌的体外活性：BACTEC法与大管肉汤稀释法的比较
J Antimicrob Chemother. 1987 May;19(5):617-22. doi: 10.1093/jac/19.5.617.
4
Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.氧氟沙星、环丙沙星和格帕沙星的抗分枝杆菌活性比较。
J Antimicrob Chemother. 1999 Nov;44(5):647-52. doi: 10.1093/jac/44.5.647.
5
Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.新型喹诺酮类药物Bay y 3118与环丙沙星对结核分枝杆菌和鸟分枝杆菌复合群的体外活性比较
J Antimicrob Chemother. 1995 Feb;35(2):349-51. doi: 10.1093/jac/35.2.349.
6
Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.抗结核药物。IX。N-（2-苯基-2-氧代乙基）和N-[2-（4-氟苯基）-2-氧代乙基]环丙沙星衍生物对部分耐多药结核分枝杆菌菌株和鸟分枝杆菌分离株的体外抗分枝杆菌活性
Boll Chim Farm. 2003 Jul-Aug;142(6):248-50.
7
8
In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.新型异噻唑酮喹诺酮 ACH-702 对结核分枝杆菌和其他分枝杆菌的体外活性。
Antimicrob Agents Chemother. 2010 May;54(5):2188-90. doi: 10.1128/AAC.01603-09. Epub 2010 Mar 15.
9
In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.恶唑烷酮类药物RBx 8700对结核分枝杆菌和鸟分枝杆菌复合群的体外杀菌活性
J Chemother. 2006 Apr;18(2):144-50. doi: 10.1179/joc.2006.18.2.144.
10
引用本文的文献
1
Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.焦磷酸测序快速检测结核分枝杆菌对利福平、异烟肼和氟喹诺酮类药物的耐药性。
J Clin Microbiol. 2009 Dec;47(12):3985-90. doi: 10.1128/JCM.01229-09. Epub 2009 Oct 21.
2
In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis.环丙沙星、氧氟沙星和左氧氟沙星对结核分枝杆菌的体外活性。
Ann Saudi Med. 2005 Sep-Oct;25(5):409-12. doi: 10.5144/0256-4947.2005.409.
3
Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.采用放射性BACTEC 460技术和固体培养基比例法对结核分枝杆菌对经典二线和新型抗菌药物的药敏试验进行多中心实验室验证。
J Clin Microbiol. 1999 Oct;37(10):3179-86. doi: 10.1128/JCM.37.10.3179-3186.1999.
本文引用的文献
1
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.分枝杆菌：药物敏感性和耐药性检测的实验室方法
Bull World Health Organ. 1963;29(5):565-78.
2
Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing.鸟分枝杆菌复合群肺部感染的治疗反应与体外药敏试验结果相关。
Am Rev Respir Dis. 1987 Feb;135(2):418-21. doi: 10.1164/arrd.1987.135.2.418.
3
Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex.抗结核药物在治疗鸟分枝杆菌复合群引起的肺部感染方面确实有效的证据。
Am Rev Respir Dis. 1988 Jan;137(1):144-8. doi: 10.1164/ajrccm/137.1.144.
4
Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.环丙沙星及其他4-喹诺酮类药物对结核分枝杆菌和胞内分枝杆菌的体外活性比较
Antimicrob Agents Chemother. 1986 Mar;29(3):386-8. doi: 10.1128/AAC.29.3.386.
5
Mycobacteria and the new quinolones.分枝杆菌与新型喹诺酮类药物。
Antimicrob Agents Chemother. 1989 Jan;33(1):1-5. doi: 10.1128/AAC.33.1.1.
6
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.使用阿米卡星、乙胺丁醇、利福平及环丙沙星治疗艾滋病患者的播散性鸟分枝杆菌复合群感染。加利福尼亚协作治疗组。
Ann Intern Med. 1990 Sep 1;113(5):358-61. doi: 10.7326/0003-4819-113-5-358.
7
Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
Arch Intern Med. 1991 Mar;151(3):582-5.
8
Ciprofloxacin treatment of multiply drug-resistant extrapulmonary tuberculosis in a child.
Pediatr Infect Dis J. 1992 May;11(5):408-9.
9
The in-vitro bactericidal activities of combinations of antimicrobial agents against clinical isolates of Mycobacterium avium-intracellulare.抗菌药物组合对鸟分枝杆菌-胞内分枝杆菌临床分离株的体外杀菌活性。
J Antimicrob Chemother. 1992 Nov;30(5):643-50. doi: 10.1093/jac/30.5.643.
10
In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.新型喹诺酮类药物洛美沙星对结核分枝杆菌的体外活性
Am Rev Respir Dis. 1992 Dec;146(6):1445-7. doi: 10.1164/ajrccm/146.6.1445.
Zotero 插件